Back to search

Article

No Evidence of Genotype‒Treatment Interactions between Endocrine Therapies and Adverse Drug Effects in Women with Breast Cancer: Findings from the UK Biobank

2025-10-24

Abstract excerpt

Breast cancer is the most commonly diagnosed cancer worldwide. Earlier studies have demonstrated that breast cancer patients with particular genomic variants are more susceptible to adverse drug effects (ADEs) when they are receiving endocrine therapy. However, to establish a robust body of evidence with regard to the potential utility and predictive value of these variants, findings from these reports require rep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3eb69c1e-ebd5-5219-b7bb-e9b80f923ad8
DOI
10.1101/2025.10.23.25338679
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
No Evidence of Genotype‒Treatment Interactions between Endocrine Therapies and Adverse Drug Effects in Women with Breast Cancer: Findings from the UK BiobankDOI 10.1101/2025.10.23.25338679
Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database InsightsSemantic proximity
The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity
Pharmacogenomics of third-generation aromatase inhibitors.Semantic proximity
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.Semantic proximity
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapySemantic proximity
Pharmacogenomics in breast cancer: current trends and future directions.Semantic proximity
Genetic prediction of long-term effects of aromatase inhibition on cancer and non-neoplastic disease riskSemantic proximity
Pharmacogenomics of breast cancer therapy: An updateSemantic proximity
The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer TreatmentSemantic proximity
Genetic variation in human drug-related genesSemantic proximity
Investigation of association between natural variants in sub-cellular pathways and breast cancer chemotherapy responseSemantic proximity
Pharmacogenomics and breast cancer.Semantic proximity
Select a neighboring publication to make it the new centre.